{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:33:50Z","timestamp":1775493230874,"version":"3.50.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T00:00:00Z","timestamp":1292630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12016-010-8221-3","type":"journal-article","created":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T06:01:33Z","timestamp":1292565693000},"page":"139-150","source":"Crossref","is-referenced-by-count":20,"title":["Cutting Edge Issues in Primary Sclerosing Cholangitis"],"prefix":"10.1007","volume":"41","author":[{"given":"Christopher L.","family":"Bowlus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,18]]},"reference":[{"key":"8221_CR1","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.3748\/wjg.14.3350","volume":"14","author":"R Chapman","year":"2008","unstructured":"Chapman R, Cullen S (2008) Etiopathogenesis of primary sclerosing cholangitis. World J Gastroenterol 14:3350\u20133359","journal-title":"World J Gastroenterol"},{"key":"8221_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2004.09.003","volume":"4","author":"CA Aoki","year":"2005","unstructured":"Aoki CA, Bowlus CL, Gershwin ME (2005) The immunobiology of primary sclerosing cholangitis. Autoimmun Rev 4:137\u2013143","journal-title":"Autoimmun Rev"},{"key":"8221_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3748\/wjg.14.331","volume":"14","author":"R Saich","year":"2008","unstructured":"Saich R, Chapman R (2008) Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol 14:331\u2013337","journal-title":"World J Gastroenterol"},{"key":"8221_CR4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00281-009-0154-7","volume":"31","author":"JH Aron","year":"2009","unstructured":"Aron JH, Bowlus CL (2009) The immunobiology of primary sclerosing cholangitis. Semin Immunopathol 31:383\u2013397","journal-title":"Semin Immunopathol"},{"key":"8221_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus Jr","year":"2005","unstructured":"Loftus EV Jr, Harewood GC, Loftus CG et al (2005) PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54:91\u201396","journal-title":"Gut"},{"key":"8221_CR6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0016-5085(89)80078-2","volume":"96","author":"JR Cangemi","year":"1989","unstructured":"Cangemi JR, Wiesner RH, Beaver SJ et al (1989) Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology 96:790\u2013794","journal-title":"Gastroenterology"},{"key":"8221_CR7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/gut.2003.036483","volume":"53","author":"TH Florin","year":"2004","unstructured":"Florin TH, Pandeya N, Radford-Smith GL (2004) Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Gut 53:973\u2013979","journal-title":"Gut"},{"key":"8221_CR8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.51.4.567","volume":"51","author":"SA Mitchell","year":"2002","unstructured":"Mitchell SA, Thyssen M, Orchard TR, Jewell DP, Fleming KA, Chapman RW (2002) Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut 51:567\u2013573","journal-title":"Gut"},{"key":"8221_CR9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1053\/gast.1996.v110.pm8613056","volume":"110","author":"KJ Erpecum van","year":"1996","unstructured":"van Erpecum KJ, Smits SJ, van de Meeberg PC et al (1996) Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology 110:1503\u20131506","journal-title":"Gastroenterology"},{"key":"8221_CR10","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","volume":"110","author":"EV Loftus Jr","year":"1996","unstructured":"Loftus EV Jr, Sandborn WJ, Tremaine WJ et al (1996) Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology 110:1496\u20131502","journal-title":"Gastroenterology"},{"key":"8221_CR11","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1053\/gast.1996.v110.agast961658","volume":"110","author":"RD Cohen","year":"1996","unstructured":"Cohen RD, Hanauer SB (1996) Protection from primary sclerosing cholangitis: smoke trails of just coattails? Gastroenterology 110:1658\u20131662","journal-title":"Gastroenterology"},{"key":"8221_CR12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.22161","volume":"16","author":"CL Bowlus","year":"2010","unstructured":"Bowlus CL, Li CS, Karlsen TH, Lie BA, Selmi C (2010) Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations. Liver Transpl 16:1324\u20131330","journal-title":"Liver Transpl"},{"key":"8221_CR13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","volume":"42","author":"A Bergquist","year":"2005","unstructured":"Bergquist A, Lindberg G, Saarinen S, Broome U (2005) Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 42:252\u2013256","journal-title":"J Hepatol"},{"key":"8221_CR14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","volume":"6","author":"A Bergquist","year":"2008","unstructured":"Bergquist A, Montgomery SM, Bahmanyar S et al (2008) Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 6:939\u2013943","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8221_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2003.11.009","volume":"40","author":"X Yang","year":"2004","unstructured":"Yang X, Cullen SN, Li JH, Chapman RW, Jewell DP (2004) Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1. J Hepatol 40:375\u2013379","journal-title":"J Hepatol"},{"key":"8221_CR16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2006.03.012","volume":"45","author":"CL Bowlus","year":"2006","unstructured":"Bowlus CL, Karlsen TH, Broome U et al (2006) Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. J Hepatol 45:704\u2013710","journal-title":"J Hepatol"},{"key":"8221_CR17","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","volume":"138","author":"TH Karlsen","year":"2010","unstructured":"Karlsen TH, Franke A, Melum E et al (2010) Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 138:1102\u20131111","journal-title":"Gastroenterology"},{"key":"8221_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00365528209182038","volume":"17","author":"E Schrumpf","year":"1982","unstructured":"Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E (1982) HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 17:187\u2013191","journal-title":"Scand J Gastroenterol"},{"key":"8221_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/gut.24.1.38","volume":"24","author":"RW Chapman","year":"1983","unstructured":"Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S (1983) Association of primary sclerosing cholangitis with HLA-B8. Gut 24:38\u201341","journal-title":"Gut"},{"key":"8221_CR20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.1840160217","volume":"16","author":"JM Farrant","year":"1992","unstructured":"Farrant JM, Doherty DG, Donaldson PT et al (1992) Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 16:390\u2013395","journal-title":"Hepatology"},{"key":"8221_CR21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","volume":"53","author":"A Spurkland","year":"1999","unstructured":"Spurkland A, Saarinen S, Boberg KM et al (1999) HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53:459\u2013469","journal-title":"Tissue Antigens"},{"key":"8221_CR22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.gene.6364377","volume":"8","author":"TH Karlsen","year":"2007","unstructured":"Karlsen TH, Boberg KM, Vatn M et al (2007) Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun 8:275\u2013278","journal-title":"Genes Immun"},{"key":"8221_CR23","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.221","volume":"40","author":"A Franke","year":"2008","unstructured":"Franke A, Balschun T, Karlsen TH et al (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40:1319\u20131323","journal-title":"Nat Genet"},{"key":"8221_CR24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/380997","volume":"74","author":"JR Oksenberg","year":"2004","unstructured":"Oksenberg JR, Barcellos LF, Cree BA et al (2004) Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 74:160\u2013167","journal-title":"Am J Hum Genet"},{"key":"8221_CR25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/jhep.2001.27543","volume":"34","author":"K Wiencke","year":"2001","unstructured":"Wiencke K, Spurkland A, Schrumpf E, Boberg KM (2001) Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 34:625\u2013630","journal-title":"Hepatology"},{"key":"8221_CR26","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/gast.2001.24041","volume":"120","author":"S Norris","year":"2001","unstructured":"Norris S, Kondeatis E, Collins R et al (2001) Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism. Gastroenterology 120:1475\u20131482","journal-title":"Gastroenterology"},{"key":"8221_CR27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0168-8278(99)80068-3","volume":"30","author":"W Bernal","year":"1999","unstructured":"Bernal W, Moloney M, Underhill J, Donaldson PT (1999) Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 30:237\u2013241","journal-title":"J Hepatol"},{"key":"8221_CR28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.49.2.288","volume":"49","author":"SA Mitchell","year":"2001","unstructured":"Mitchell SA, Grove J, Spurkland A et al (2001) Association of the tumour necrosis factor alpha -308 but not the interleukin 10\u2013627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 49:288\u2013294","journal-title":"Gut"},{"key":"8221_CR29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jhep.2007.01.032","volume":"46","author":"TH Karlsen","year":"2007","unstructured":"Karlsen TH, Boberg KM, Olsson M et al (2007) Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J Hepatol 46:899\u2013906","journal-title":"J Hepatol"},{"key":"8221_CR30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-065X.2006.00459.x","volume":"214","author":"SI Khakoo","year":"2006","unstructured":"Khakoo SI, Carrington M (2006) KIR and disease: a model system or system of models? Immunol Rev 214:186\u2013201","journal-title":"Immunol Rev"},{"key":"8221_CR31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2009.11.029","volume":"52","author":"JR Hov","year":"2010","unstructured":"Hov JR, Lleo A, Selmi C et al (2010) Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C. J Hepatol 52:712\u2013717","journal-title":"J Hepatol"},{"key":"8221_CR32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2350-9-81","volume":"9","author":"P Gaj","year":"2008","unstructured":"Gaj P, Habior A, Mikula M, Ostrowski J (2008) Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn\u2019s disease in Polish patients. BMC Med Genet 9:81","journal-title":"BMC Med Genet"},{"key":"8221_CR33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1572-0241.2006.00928.x","volume":"102","author":"TH Karlsen","year":"2007","unstructured":"Karlsen TH, Hampe J, Wiencke K et al (2007) Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol 102:115\u2013121","journal-title":"Am J Gastroenterol"},{"key":"8221_CR34","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/ard.2007.077826","volume":"67","author":"MC Eike","year":"2008","unstructured":"Eike MC, Nordang GB, Karlsen TH et al (2008) The FCRL3\u2013169T > C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases. Ann Rheum Dis 67:1287\u20131291","journal-title":"Ann Rheum Dis"},{"key":"8221_CR35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ng.148","volume":"40","author":"A Franke","year":"2008","unstructured":"Franke A, Balschun T, Karlsen TH et al (2008) Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 40:713\u2013715","journal-title":"Nat Genet"},{"key":"8221_CR36","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/ng.145","volume":"40","author":"SA Fisher","year":"2008","unstructured":"Fisher SA, Tremelling M, Anderson CA et al (2008) Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 40:710\u2013712","journal-title":"Nat Genet"},{"key":"8221_CR37","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ajg.2008.112","volume":"104","author":"RK Weersma","year":"2009","unstructured":"Weersma RK, Stokkers PC, Cleynen I et al (2009) Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol 104:630\u2013638","journal-title":"Am J Gastroenterol"},{"key":"8221_CR38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","volume":"372","author":"V Keitel","year":"2008","unstructured":"Keitel V, Donner M, Winandy S, Kubitz R, Haussinger D (2008) Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun 372:78\u201384","journal-title":"Biochem Biophys Res Commun"},{"key":"8221_CR39","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","volume":"278","author":"Y Kawamata","year":"2003","unstructured":"Kawamata Y, Fujii R, Hosoya M et al (2003) A G protein-coupled receptor responsive to bile acids. J Biol Chem 278:9435\u20139440","journal-title":"J Biol Chem"},{"key":"8221_CR40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","volume":"50","author":"V Keitel","year":"2009","unstructured":"Keitel V, Cupisti K, Ullmer C, Knoefel WT, Kubitz R, Haussinger D (2009) The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology 50:861\u2013870","journal-title":"Hepatology"},{"key":"8221_CR41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2008.07.033","volume":"50","author":"L Henckaerts","year":"2009","unstructured":"Henckaerts L, Jaspers M, Van Steenbergen W et al (2009) Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis. J Hepatol 50:150\u2013157","journal-title":"J Hepatol"},{"key":"8221_CR42","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00452.2003","volume":"287","author":"PG Blanco","year":"2004","unstructured":"Blanco PG, Zaman MM, Junaidi O et al (2004) Induction of colitis in cftr-\/- mice results in bile duct injury. Am J Physiol Gastrointest Liver Physiol 287:G491\u2013G496","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"8221_CR43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00439-003-0963-z","volume":"113","author":"S Sheth","year":"2003","unstructured":"Sheth S, Shea JC, Bishop MD et al (2003) Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet 113:286\u2013292","journal-title":"Hum Genet"},{"key":"8221_CR44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0168-8278(02)00161-7","volume":"37","author":"E Girodon","year":"2002","unstructured":"Girodon E, Sternberg D, Chazouilleres O et al (2002) Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis. J Hepatol 37:192\u2013197","journal-title":"J Hepatol"},{"key":"8221_CR45","doi-asserted-by":"crossref","first-page":"e12403","DOI":"10.1371\/journal.pone.0012403","volume":"5","author":"JR Hov","year":"2010","unstructured":"Hov JR, Keitel V, Laerdahl JK et al (2010) Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS ONE 5:e12403","journal-title":"PLoS ONE"},{"key":"8221_CR46","doi-asserted-by":"crossref","unstructured":"Chan SW, Lim CJ, Chen L et al (2010) The hippo pathway in biological control and cancer development. J Cell Physiol. doi: 10.1002\/jcp.22435","DOI":"10.1002\/jcp.22435"},{"key":"8221_CR47","doi-asserted-by":"crossref","first-page":"38104","DOI":"10.1074\/jbc.M206167200","volume":"277","author":"YQ Zhou","year":"2002","unstructured":"Zhou YQ, Chen YQ, Fisher JH, Wang MH (2002) Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J Biol Chem 277:38104\u201338110","journal-title":"J Biol Chem"},{"key":"8221_CR48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2010.03.007","volume":"32","author":"M Raab","year":"2010","unstructured":"Raab M, Wang H, Lu Y et al (2010) T cell receptor \u201cinside-out\u201d pathway via signaling module SKAP1-RapL regulates T cell motility and interactions in lymph nodes. Immunity 32:541\u2013556","journal-title":"Immunity"},{"key":"8221_CR49","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/emboj.2009.82","volume":"28","author":"K Katagiri","year":"2009","unstructured":"Katagiri K, Katakai T, Ebisuno Y, Ueda Y, Okada T, Kinashi T (2009) Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO J 28:1319\u20131331","journal-title":"EMBO J"},{"key":"8221_CR50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/mi.2007.15","volume":"1","author":"P Goyette","year":"2008","unstructured":"Goyette P, Lefebvre C, Ng A et al (2008) Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol 1:131\u2013138","journal-title":"Mucosal Immunol"},{"key":"8221_CR51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2567.2008.02939.x","volume":"125","author":"ME Himmel","year":"2008","unstructured":"Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK (2008) The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology 125:145\u2013153","journal-title":"Immunology"},{"key":"8221_CR52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ng1954","volume":"39","author":"J Hampe","year":"2007","unstructured":"Hampe J, Franke A, Rosenstiel P et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39:207\u2013211","journal-title":"Nat Genet"},{"key":"8221_CR53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature 411:603\u2013606","journal-title":"Nature"},{"key":"8221_CR54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 411:599\u2013603","journal-title":"Nature"},{"key":"8221_CR55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","volume":"26","author":"CA O\u2019Mahony","year":"2006","unstructured":"O\u2019Mahony CA, Vierling JM (2006) Etiopathogenesis of primary sclerosing cholangitis. Semin Liver Dis 26:3\u201321","journal-title":"Semin Liver Dis"},{"key":"8221_CR56","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","volume":"48","author":"E Seki","year":"2008","unstructured":"Seki E, Brenner DA (2008) Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48:322\u2013335","journal-title":"Hepatology"},{"key":"8221_CR57","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2007.01.039","volume":"132","author":"A Karrar","year":"2007","unstructured":"Karrar A, Broome U, Sodergren T et al (2007) Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 132:1504\u20131514","journal-title":"Gastroenterology"},{"key":"8221_CR58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-9120(01)00215-6","volume":"34","author":"RG Cameron","year":"2001","unstructured":"Cameron RG, Blendis LM, Neuman MG (2001) Accumulation of macrophages in primary sclerosing cholangitis. Clin Biochem 34:195\u2013201","journal-title":"Clin Biochem"},{"key":"8221_CR59","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/hep.1840380428","volume":"38","author":"CT Wu","year":"2003","unstructured":"Wu CT, Eiserich JP, Ansari AA et al (2003) Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. Hepatology 38:1018\u20131025","journal-title":"Hepatology"},{"key":"8221_CR60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0168-8278(01)00084-8","volume":"35","author":"K Tsuneyama","year":"2001","unstructured":"Tsuneyama K, Harada K, Kono N et al (2001) Scavenger cells with gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis. J Hepatol 35:156\u2013163","journal-title":"J Hepatol"},{"key":"8221_CR61","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0016-5085(88)90560-4","volume":"94","author":"CH Hobson","year":"1988","unstructured":"Hobson CH, Butt TJ, Ferry DM, Hunter J, Chadwick VS, Broom MF (1988) Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. Gastroenterology 94:1006\u20131013","journal-title":"Gastroenterology"},{"key":"8221_CR62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF01308179","volume":"37","author":"RP Anderson","year":"1992","unstructured":"Anderson RP, Butt TJ, Chadwick VS (1992) Hepatobiliary excretion of bacterial formyl-methionyl peptides in rat. Structure activity studies. Dig Dis Sci 37:248\u2013256","journal-title":"Dig Dis Sci"},{"key":"8221_CR63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1440-1746.1990.tb01765.x","volume":"5","author":"CH Hobson","year":"1990","unstructured":"Hobson CH, Roberts EC, Broom MF, Mellor DM, Sherriff RM, Chadwick VS (1990) Radio-immunoassay for formyl methionyl leucyl phenylalanine. I. Development and application to assessment of chemotactic peptide production by enteric bacteria. J Gastroenterol Hepatol 5:32\u201337","journal-title":"J Gastroenterol Hepatol"},{"key":"8221_CR64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1478-3231.1999.tb00043.x","volume":"19","author":"S Yamada","year":"1999","unstructured":"Yamada S, Ishii M, Kisara N, Nagatomi R, Toyota T (1999) Macrophages are essential for lymphocyte infiltration in formyl peptide-induced cholangitis in rat liver. Liver 19:253\u2013258","journal-title":"Liver"},{"key":"8221_CR65","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF02365447","volume":"29","author":"S Yamada","year":"1994","unstructured":"Yamada S, Ishii M, Liang LS, Yamamoto T, Toyota T (1994) Small duct cholangitis induced by N-formyl l-methionine l-leucine l-tyrosine in rats. J Gastroenterol 29:631\u2013636","journal-title":"J Gastroenterol"},{"key":"8221_CR66","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0016-5085(90)90833-M","volume":"98","author":"SN Lichtman","year":"1990","unstructured":"Lichtman SN, Sartor RB, Keku J, Schwab JH (1990) Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology 98:414\u2013423","journal-title":"Gastroenterology"},{"key":"8221_CR67","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0016-5085(91)90224-9","volume":"100","author":"SN Lichtman","year":"1991","unstructured":"Lichtman SN, Keku J, Schwab JH, Sartor RB (1991) Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 100:513\u2013519","journal-title":"Gastroenterology"},{"key":"8221_CR68","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI115996","volume":"90","author":"SN Lichtman","year":"1992","unstructured":"Lichtman SN, Okoruwa EE, Keku J, Schwab JH, Sartor RB (1992) Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Invest 90:1313\u20131322","journal-title":"J Clin Invest"},{"key":"8221_CR69","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/00365520510023288","volume":"40","author":"E Bjornsson","year":"2005","unstructured":"Bjornsson E, Cederborg A, Akvist A, Simren M, Stotzer PO, Bjarnason I (2005) Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis. Scand J Gastroenterol 40:1090\u20131094","journal-title":"Scand J Gastroenterol"},{"key":"8221_CR70","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00042737-200206000-00009","volume":"14","author":"CY Ponsioen","year":"2002","unstructured":"Ponsioen CY, Defoer J, Ten Kate FJ et al (2002) A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved? Eur J Gastroenterol Hepatol 14:641\u2013648","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"8221_CR71","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s10620-007-9803-7","volume":"52","author":"AM Krasinskas","year":"2007","unstructured":"Krasinskas AM, Yao Y, Randhawa P, Dore MP, Sepulveda AR (2007) Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis. Dig Dis Sci 52:2265\u20132270","journal-title":"Dig Dis Sci"},{"key":"8221_CR72","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.femsim.2004.11.002","volume":"44","author":"SY Boomkens","year":"2005","unstructured":"Boomkens SY, de Rave S, Pot RG et al (2005) The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis. FEMS Immunol Med Microbiol 44:221\u2013225","journal-title":"FEMS Immunol Med Microbiol"},{"key":"8221_CR73","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2036.2002.01282.x","volume":"16","author":"RW Leong","year":"2002","unstructured":"Leong RW, Sung JJ (2002) Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 16:1037\u20131045","journal-title":"Aliment Pharmacol Ther"},{"key":"8221_CR74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00042737-200601000-00012","volume":"18","author":"J Pohl","year":"2006","unstructured":"Pohl J, Ring A, Stremmel W, Stiehl A (2006) The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 18:69\u201374","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"8221_CR75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/17402520600800085","volume":"13","author":"CA Aoki","year":"2006","unstructured":"Aoki CA, Dawson K, Kenny TP, Gershwin ME, Bowlus CL (2006) Gene expression by PBMC in primary sclerosing cholangitis: evidence for dysregulation of immune mediated genes. Clin Dev Immunol 13:265\u2013271","journal-title":"Clin Dev Immunol"},{"key":"8221_CR76","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1042\/BST0340446","volume":"34","author":"CM Milner","year":"2006","unstructured":"Milner CM, Higman VA, Day AJ (2006) TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans 34:446\u2013450","journal-title":"Biochem Soc Trans"},{"key":"8221_CR77","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","volume":"359","author":"AJ Grant","year":"2002","unstructured":"Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH (2002) Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet 359:150\u2013157","journal-title":"Lancet"},{"key":"8221_CR78","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2009.02.046","volume":"137","author":"B Eksteen","year":"2009","unstructured":"Eksteen B, Mora JR, Haughton EL et al (2009) Gut homing receptors on CD8 T-cells ARE retinoic acid dependent and not maintained by liver dendritic or stellate cells. Gastroenterol 137:320\u2013329","journal-title":"Gastroenterol"},{"key":"8221_CR79","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4049\/jimmunol.177.1.593","volume":"177","author":"B Eksteen","year":"2006","unstructured":"Eksteen B, Miles A, Curbishley SM et al (2006) Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J Immunol 177:593\u2013603","journal-title":"J Immunol"},{"key":"8221_CR80","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","volume":"200","author":"B Eksteen","year":"2004","unstructured":"Eksteen B, Grant AJ, Miles A et al (2004) Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 200:1511\u20131517","journal-title":"J Exp Med"},{"key":"8221_CR81","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0002-9440(10)62570-9","volume":"160","author":"AJ Grant","year":"2002","unstructured":"Grant AJ, Goddard S, Ahmed-Choudhury J et al (2002) Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 160:1445\u20131455","journal-title":"Am J Pathol"},{"key":"8221_CR82","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jhep.2001.24231","volume":"33","author":"AJ Grant","year":"2001","unstructured":"Grant AJ, Lalor PF, Hubscher SG, Briskin M, Adams DH (2001) MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease). Hepatology 33:1065\u20131072","journal-title":"Hepatology"},{"key":"8221_CR83","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4049\/jimmunol.161.3.1549","volume":"161","author":"R Kurkijarvi","year":"1998","unstructured":"Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M (1998) Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol 161:1549\u20131557","journal-title":"J Immunol"},{"key":"8221_CR84","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.4049\/jimmunol.0901216","volume":"184","author":"YH Oo","year":"2010","unstructured":"Oo YH, Weston CJ, Lalor PF et al (2010) Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol 184:2886\u20132898","journal-title":"J Immunol"},{"key":"8221_CR85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2009.07.011","volume":"34","author":"YH Oo","year":"2010","unstructured":"Oo YH, Adams DH (2010) The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 34:45\u201354","journal-title":"J Autoimmun"},{"key":"8221_CR86","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00281-009-0167-2","volume":"31","author":"AT Borchers","year":"2009","unstructured":"Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME (2009) Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol 31:309\u2013322","journal-title":"Semin Immunopathol"},{"key":"8221_CR87","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1478-3231.1999.tb00084.x","volume":"19","author":"KJ Hillan","year":"1999","unstructured":"Hillan KJ, Hagler KE, MacSween RN et al (1999) Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease. Liver 19:509\u2013518","journal-title":"Liver"},{"key":"8221_CR88","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2008.04.009","volume":"135","author":"E Patsenker","year":"2008","unstructured":"Patsenker E, Popov Y, Stickel F, Jonczyk A, Goodman SL, Schuppan D (2008) Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology 135:660\u2013670","journal-title":"Gastroenterology"},{"key":"8221_CR89","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s10354-008-0592-1","volume":"158","author":"M Trauner","year":"2008","unstructured":"Trauner M, Fickert P, Halilbasic E, Moustafa T (2008) Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases. Wien Med Wochenschr 158:542\u2013548","journal-title":"Wien Med Wochenschr"},{"key":"8221_CR90","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","volume":"123","author":"P Fickert","year":"2002","unstructured":"Fickert P, Zollner G, Fuchsbichler A et al (2002) Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123:1238\u20131251","journal-title":"Gastroenterology"},{"key":"8221_CR91","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","volume":"43","author":"Y Popov","year":"2005","unstructured":"Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D (2005) Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 43:1045\u20131054","journal-title":"J Hepatol"},{"key":"8221_CR92","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1478-3231.2009.02044.x","volume":"29","author":"J Jahnel","year":"2009","unstructured":"Jahnel J, Fickert P, Langner C et al (2009) Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice. Liver Int 29:1316\u20131325","journal-title":"Liver Int"},{"key":"8221_CR93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","volume":"127","author":"P Fickert","year":"2004","unstructured":"Fickert P, Fuchsbichler A, Wagner M et al (2004) Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 127:261\u2013274","journal-title":"Gastroenterology"},{"key":"8221_CR94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-6-3","volume":"6","author":"P Fickert","year":"2007","unstructured":"Fickert P, Moustafa T, Trauner M (2007) Primary sclerosing cholangitis\u2014the arteriosclerosis of the bile duct? Lipids Health Dis 6:3","journal-title":"Lipids Health Dis"},{"key":"8221_CR95","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1572-0241.2005.41072.x","volume":"100","author":"JF Gallegos-Orozco","year":"2005","unstructured":"Gallegos-Orozco JF, Yurk C E, Wang N et al (2005) Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. Am J Gastroenterol 100:874\u2013878","journal-title":"Am J Gastroenterol"},{"key":"8221_CR96","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/BF02282335","volume":"41","author":"JM McGill","year":"1996","unstructured":"McGill JM, Williams DM, Hunt CM (1996) Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis. Dig Dis Sci 41:540\u2013542","journal-title":"Dig Dis Sci"},{"key":"8221_CR97","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1872-034X.2010.00698.x","volume":"40","author":"GU Denk","year":"2010","unstructured":"Denk GU, Bikker H, Lekanne Dit Deprez RH et al (2010) ABCB4 deficiency: a family saga of early onset cholelithiasis, sclerosing cholangitis and cirrhosis and a novel mutation in the ABCB4 gene. Hepatol Res 40:937\u2013941","journal-title":"Hepatol Res"},{"key":"8221_CR98","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.gcb.2010.04.011","volume":"34","author":"R Poupon","year":"2010","unstructured":"Poupon R, Arrive L, Rosmorduc O (2010) The cholangiographic features of severe forms of ABCB4\/MDR3 deficiency-associated cholangiopathy in adults. Gastroent\u00e9rol Clin Biol 34:380\u2013387","journal-title":"Gastroent\u00e9rol Clin Biol"},{"key":"8221_CR99","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20159","volume":"39","author":"C Pauli-Magnus","year":"2004","unstructured":"Pauli-Magnus C, Kerb R, Fattinger K et al (2004) BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 39:779\u2013791","journal-title":"Hepatology"},{"key":"8221_CR100","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2004.02.042","volume":"126","author":"O Rosmorduc","year":"2004","unstructured":"Rosmorduc O, Hermelin B, Boelle PY, Poupon RE, Poupon R, Chazouilleres O (2004) ABCB4 gene mutations and primary sclerosing cholangitis. Gastroenterology 126:1220\u20131222, author reply 1222-3","journal-title":"Gastroenterology"},{"key":"8221_CR101","first-page":"283","volume":"23","author":"A Stiehl","year":"1995","unstructured":"Stiehl A, Rudolph G, Sauer P, Theilmann L (1995) Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. J Hepatol 23:283\u2013289","journal-title":"J Hepatol"},{"key":"8221_CR102","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1053\/j.gastro.2006.05.057","volume":"131","author":"TH Karlsen","year":"2006","unstructured":"Karlsen TH, Lie BA, Frey Froslie K et al (2006) Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis. Gastroenterology 131:781\u2013787","journal-title":"Gastroenterology"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8221-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-010-8221-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8221-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T14:45:08Z","timestamp":1685889908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-010-8221-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,18]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["8221"],"URL":"https:\/\/doi.org\/10.1007\/s12016-010-8221-3","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,18]]}}}